Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients withStaphylococcus aureusSurgical Site Infection

Clinical Infectious Diseases - Tập 36 Số 5 - Trang 592-598 - 2003
John J. Engemann1, Yehuda Carmeli2, Sara E. Cosgrove3, Vance G. Fowler1, Melissa Bronstein4, Sharon L. Trivette5, Jane Briggs5, Daniel J. Sexton4,5,1, Keith S. Kaye4,5,1
1Division of Infectious Diseases, Department of Medicine, Durham, North Carolina
2Division of Infectious Diseases, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts
3Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland
4Department of Infection Control, Duke University Medical Center, Durham, North Carolina
5Department of Infection Control, Durham Regional Hospital, Durham, North Carolina

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1086/321859

Weinstein RA, 1998, Emerg Infect Dis, 4, 416, 10.3201/eid0403.980320

10.1016/S0196-6553(96)90026-7

10.1086/324622

10.1067/mic.2001.119952

Menon KV, 1999, J R Coll Surg Edinb, 44, 161

Hershow RC, 1992, Infect Control Hosp Epidemiol, 13, 587, 10.2307/30148461

10.1001/archsurg.134.10.1033

Rello J, 1994, Am J Respir Crit Care Med, 150, 1545, 10.1164/ajrccm.150.6.7952612

10.1016/0195-6701(90)90120-D

Mylotte JM, 1996, Infect Control Hosp Epidemiol, 17, 165, 10.2307/30142375

10.1086/319355

10.1001/archinte.159.11.1244

10.1086/322610

10.1086/313440

10.1086/501707

10.1086/313650

10.1016/S0196-6553(85)80011-0

10.1001/archinte.160.7.1001

10.1001/archinte.158.2.182

Conterno LO, 1998, Infect Control Hosp Epidemiol, 19, 32, 10.2307/30141354

Craven DE, 1983, J Infect Dis, 147, 137, 10.1093/infdis/147.1.137

Romero-Vivas J, 1995, Clin Infect Dis, 21, 1417, 10.1093/clinids/21.6.1417

Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charge [abstract K-1221]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001:415.

10.1086/501641

10.1007/BF01690549

10.1001/jama.282.18.1745

10.1086/501871

10.1016/0196-6553(88)90053-3

10.1097/00000542-197810000-00003

Culver DH, 1991, National Nosocomial Infections Surveillance System. Am J Med, 91, 152S

National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: 12th international supplement. NCCLS document M100-S12:22:1. Wayne, PA: NCCLS, 2002.

Whitby M, 2001, Med J Aust, 175, 264, 10.5694/j.1326-5377.2001.tb143562.x

Levine DP, 1991, Ann Intern Med, 115, 674, 10.7326/0003-4819-115-9-674

Hartstein AI, 1992, J Clin Microbiol, 30, 670, 10.1128/JCM.30.3.670-674.1992

10.1001/jama.274.21.1706

Zanetti G, 2001, Emerg Infect Dis, 7, 820, 10.3201/eid0705.010508